Bristol-Myers Squibb in its $90 billion acquisition of Celgene, including its related $13.4 billion divesture of Celgene’s OTEZLA® program to Amgen
The Simply Good Foods Company in its $1 billion acquisition of Quest Nutrition, LLC
AbbVie in its pending $63 billion acquisition of Allergan
Amplify Energy Corp. in an all-stock merger-of-equals with Midstates Petroleum Company, Inc.
Caisse de dépôt et placement du Québec in its major investment in Allied Universal
HGGC in its $825 million take-private acquisition of Monotype Imaging Holdings
Clayton, Dubilier & Rice in its acquisition of Sirius Computer Solutions
Cision Ltd. in its $2.74 billion sale to an affiliate of Platinum Equity
Arya Sciences Acquisition Corp. in its pending combination with Immatics Biotechnologies GmbH
